Amplia Therapeutics Ltd.ASX: ATX

Completion of Phase 2B Trial of MIS416

Apr 20, 2017 at 2:53 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment